LAMODEX 100 MG DISPERSIBLECHEWABLE TABLETS

Country: Israel

Bahasa: Inggeris

Sumber: Ministry of Health

Beli sekarang

Risalah maklumat Risalah maklumat (PIL)
25-07-2022
Laporan Penilaian Awam Laporan Penilaian Awam (PAR)
24-01-2021

Bahan aktif:

LAMOTRIGINE

Boleh didapati daripada:

DEXCEL LTD, ISRAEL

Kod ATC:

N03AX09

Borang farmaseutikal:

DISPERSIBLE/CHEWABLE TABLETS

Komposisi:

LAMOTRIGINE 100 MG

Laluan pentadbiran:

PER OS

Jenis preskripsi:

Required

Dikeluarkan oleh:

DEXCEL LTD, ISRAEL

Kumpulan terapeutik:

LAMOTRIGINE

Kawasan terapeutik:

LAMOTRIGINE

Tanda-tanda terapeutik:

Epilepsy • Adults and adolescents aged 13 years and above: - Adjunctive or monotherapy treatment of partial seizures and generalised seizures, including tonic-clonic seizures. - Seizures associated with Lennox-Gastaut syndrome. Lamodex is given as adjunctive therapy but may be the initial antiepileptic drug (AED) to start with in Lennox-Gastaut syndrome. • Children and adolescents aged 2 to 12 years: - Adjunctive treatment of partial seizures and generalised seizures, including tonic-clonic seizures and the seizures associated with Lennox-Gastaut syndrome. - Monotherapy of typical absence seizures.Bipolar disorder • Adults aged 18 years and above - Prevention of depressive episodes in patients with bipolar I disorder who experience predominantly depressive episodes.Lamodex is not indicated for the acute treatment of manic or depressive episodes.

Tarikh kebenaran:

2013-12-31

Risalah maklumat

                                Each tablet contains lamotrigine at a dosage of 5, 25, 50,
100 or 200 mg, respectively.
Inactive ingredients and allergens in the medicine - see
section 6 “Additional information” and in section 2 “Important
information about some of the ingredients of this medicine”.
READ
THIS
ENTIRE
LEAFLET
CAREFULLY
BEFORE
USING
THIS
MEDICINE. This leaflet contains concise information about
the medicine. If you have any further questions, ask the
doctor or pharmacist.
This medicine has been prescribed for you. Do not pass it
on to others. It may harm them, even if you think that their
medical condition is the same as yours.
1. WHAT IS THE MEDICINE INTENDED FOR?
LAMODEX
IS
INTENDED
FOR
THE
TREATMENT
OF
EPILEPSY
(LAMODEX 5, 25, 50, 100, 200 MG DISPERSIBLE/CHEWABLE
TABLETS)
In adults and adolescents aged 13 years and above: LAMODEX is given as monotherapy or in combination with
other medicines to treat partial seizures and generalized
seizures, including tonic-clonic seizures.
Seizures
that
occur
with
Lennox-Gastaut
syndrome.
LAMODEX is given as combination therapy with other
medicines but may be used as the initial anti-epileptic
drug to start treatment in Lennox-Gastaut syndrome.
In children and adolescents aged 2 to 12 years: LAMODEX is given as combination therapy with other
medicines
to
treat
partial
seizures
and
generalized
seizures, including tonic-clonic seizures and seizures
occurring
with
Lennox-Gastaut
syndrome. LAMODEX is given as monotherapy in typical absence
seizures.
LAMODEX IS INTENDED FOR TREATMENT OF BIPOLAR DISORDER
(LAMODEX 25, 50, 100, 200 MG DISPERSIBLE/CHEWABLE
TABLETS)
In adults aged 18 years and above: LAMODEX
is
given
to
prevent
depressive
episodes
in
patients
with
bipolar
disorder
I
who
experience
predominantly depressive episodes.
LAMODEX is not intended for the acute treatment of manic
or depressive episodes.
THERAPEUTIC
GROUP:
LAMODEX
belongs
to
a
group
of
medicines called anticonvulsants.
LAMODEX
blocks
the
signals
in
the
brain
that
trigger
epileptic seizures.
2. BEFORE USING THE MEDICINE
D
                                
                                Baca dokumen lengkap
                                
                            

Dokumen dalam bahasa lain

Risalah maklumat Risalah maklumat Arab 25-07-2022
Risalah maklumat Risalah maklumat Ibrani 31-07-2022

Cari amaran yang berkaitan dengan produk ini